Skip to main content

Biotech Acquisition Company (BIOT)

NASDAQ: BIOT · IEX Real-Time Price · USD
9.70 -0.01 (-0.10%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap223.10M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out23.00M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.71
Day's Range9.66 - 9.70
52-Week Range9.54 - 9.95
Price Targetn/a
Est. Earnings Daten/a

About BIOT

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

IPO DateJan 26, 2021
Stock ExchangeNASDAQ
Ticker SymbolBIOT
Full Company Profile


Biotech Acquisition Company Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 1...

NEW YORK, March 15, 2021 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOTU) (the "Company") announced that, commencing March 18, 2021, holders of the units sold in the Company's initial public ...

6 months ago - PRNewsWire

Biotech Acquisition Company Announces Closing of $230,000,000 Initial Public Offering

New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units ...

7 months ago - GlobeNewsWire

Biotech Acquisition Company Announces Pricing of $200 Million Initial Public Offering

New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acqui...

7 months ago - GlobeNewsWire

SPRIM-backed SPAC Biotech Acquisition files for a $200 million IPO

Biotech Acquisition Company, a blank check company formed by CRO and venture investor SPRIM targeting the biotech industry, filed on Thursday with the SEC for an initial public offering.

8 months ago - NASDAQ

Biotech Acquisition IPO Registration Document (S-1)

Biotech Acquisition Company has filed to go public with an IPO on the NASDAQ.

8 months ago - SEC